A new bill proposed in the New York Assembly, A10104, aims to allow pets with certain medical conditions access to medical grade CBD oil via a licensed veterinarians prescription.
Natural pet supplement sales have nearly doubled between 2008 and 2014, with an increase in sales that have shown the U.S. retail market to be worth $1.6B.
The new bill will provide pets access to hemp derived, high quality, Cannabidiol, or better known to the public as CBD oil. CBD oil has been known as useful in pets treating separation anxiety, epilepsy and other various inflammatory conditions.
Bill A10104 currently rests in the hands of the New York Senate Health Committee for approval.